EXOCOBIO INC.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™) 2023-05-19 16:34
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA 2023-03-02 14:09
ExoCoBio's First Global Regenerative Aesthetic Exosome Summit 2022-08-16 15:00
ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome 2022-05-09 07:00
ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility 2021-08-25 19:44
ExoCoBio Inc. raises $9.3M in Pre-IPO Financing 2020-08-25 22:00
1